12:00 AM
 | 
Jun 18, 2012
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 6/15 cls
Basilea Pharmaceutica AG (SIX:BSLN) Jefferies Philippa Gardner Price target Hold 3% CHF44.05
Gardner raised her target to CHF51 from CHF45 after Basilea granted Stiefel Laboratories Inc. exclusive, worldwide rights to its only marketed drug, eczema therapy Toctino alitretinoin (see B6). She said "Toctino will likely be more successful in...

Read the full 448 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >